Compare FICO & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FICO | WST |
|---|---|---|
| Founded | 1956 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3B | 25.6B |
| IPO Year | 1995 | 2004 |
| Metric | FICO | WST |
|---|---|---|
| Price | $1,160.01 | $356.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $1,689.92 | $325.86 |
| AVG Volume (30 Days) | 383.8K | ★ 602.3K |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | ★ 29.78 | 1.49 |
| EPS | ★ 28.12 | 4.07 |
| Revenue | $1,032,475,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $27.28 | $6.76 |
| Revenue Next Year | $16.97 | $6.22 |
| P/E Ratio | ★ $41.31 | $86.68 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $870.01 | $223.83 |
| 52 Week High | $1,998.01 | $386.00 |
| Indicator | FICO | WST |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 55.46 |
| Support Level | $1,067.18 | $349.41 |
| Resistance Level | $1,329.48 | $358.67 |
| Average True Range (ATR) | 47.33 | 6.41 |
| MACD | 9.92 | 0.13 |
| Stochastic Oscillator | 89.70 | 64.69 |
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.